Semi-Annual Consolidated Statement Of Cash Flows

Fuso Pharmaceutical Industries,Ltd. - Filing #7599190

Concept As at
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
As at
2020-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
4,572,000,000 JPY
3,537,000,000 JPY
Interest and dividends received
82,000,000 JPY
79,000,000 JPY
Interest paid
-176,000,000 JPY
-195,000,000 JPY
Income taxes paid
-979,000,000 JPY
-190,000,000 JPY
Net cash provided by (used in) operating activities
3,498,000,000 JPY
3,230,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,408,000,000 JPY
-1,182,000,000 JPY
Proceeds from sale of property, plant and equipment
JPY
130,000,000 JPY
Purchase of investment securities
-47,000,000 JPY
JPY
Proceeds from sale of investment securities
JPY
40,000,000 JPY
Other, net
-125,000,000 JPY
17,000,000 JPY
Net cash provided by (used in) investing activities
-1,553,000,000 JPY
-978,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
2,890,000,000 JPY
2,400,000,000 JPY
Repayments of long-term borrowings
-4,032,000,000 JPY
-4,314,000,000 JPY
Purchase of treasury shares
-2,000,000 JPY
-4,000,000 JPY
Dividends paid
-525,000,000 JPY
-525,000,000 JPY
Net cash provided by (used in) financing activities
-1,671,000,000 JPY
-2,446,000,000 JPY
Other, net
0 JPY
JPY
Net increase (decrease) in cash and cash equivalents
273,000,000 JPY
-194,000,000 JPY
Cash and cash equivalents
7,347,000,000 JPY
7,074,000,000 JPY
7,268,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.